All Photos(1)




PPM1D Phosphatase Inhibitor II, GSK2830371

Sign Into View Organizational & Contract Pricing

Select a Size

PPM1D Phosphatase Inhibitor II, GSK2830371, ( S)-5-((5-Chloro-2-methylpyridin-3-ylamino)methyl)-N-(3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)thiophene-2-carboxamide, PP2Cδ Inhibitor II, Wip1 Inhibitor II, WT-53-Induced Phosphatase Inhibitor; GSK 2830371, (S)-5-((5-Chloro-2-methylpyridin-3-ylamino)methyl)-N-(3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)thiophene-2-carboxamide, PP2Cδ Inhibitor II, Wip1 Inhibitor II, WT-53-Induced Phosphatase Inhibitor; GSK 2830371
Empirical Formula (Hill Notation):
Molecular Weight:


≥97% (HPLC)

Quality Level





storage condition

OK to freeze


light yellow


DMSO: 100 mg/mL

storage temp.


General description

A cell-permeable pyridinylaminomethylthienylcarboxamide that acts as a potent inhibitor against wild-type p53-induced phosphatase Wip1/PPM1D/PP2Cδ activity (IC50/[wip1]/[substrate]= 6 nM/1 nM Wip1/50 µM FDP and 13 nM/15 nM Wip1/8 nM pT180 p38) via an allosteric interaction with the ′flap′ region outside the catalytic site in a reversible and substrate-noncompetitive manner, while exhibiting little potency toward yeast YopH and 22 other human phosphatases (IC50 >30 µM), including PPM1A/PP2Cα & PPM1K/PP2Cκ. Shown to increase cellular Wip1 substrates phosphorylation, including p53 (S15), Chk2 (T68), H2AX (S139), and ATM (S1981), leading to p53 response protein p21/Waf1 upregulation and selective growth inhibition against breast cancer MCF-7 (IC50 = 500 nM in 14-d colony formation assay) and 22 lymphoid cell lines (IC50 from 24 nM to 2.2 µM in 7-d viability assay) expressing wt p53, but not BT474 breast cancer or a panel of 25 hematologic cancer cultures with mutant p53 status (IC50 >10 µM). Albeit short in vivo half-life, frequent and high daily oral dosages effectively suppress B-cell lymphoma DoHH2-derived tumor growth in mice (by 41% and 68% in 14 days with 75 mg/kg/12 h or 150 mg/kg/8 h oral dosage, respectively) in vivo. In addition to direct inhibition against Wip1 phosphatase activity, GSK2830371 binding also results in downregulation of cellular Wip1 protein, but not mRNA, level due to ubiquitination-dependent degradation. MG-132 (Cat. Nos. 474790, 474787, 474788, and 474791) effectively prevents GSK2830371-induced Wip1 degradation without interfering with the phosphorylation enhancing effect of GSK2830371 toward Wip1 substrates.
A cell-permeable, orally available pyridinylaminomethylthienylcarboxamide compound that acts as a potent, allosteric, non-competitive, and reversible inhibitor of wild-type p53-induced phosphatase (Wip1; IC50 = 6 nM for dephosphorylation of fluorescein diphosphate by Wip1 (2-240) and 13 nM for phospho-p38 MAP kinase (Thr180)). Does not affect the activity of 21 other phosphatases studied (IC50 ≥ 30 µM). Binds to the flap region in close proximity to Wip1 catalytic site and impairs ubiquitin-mediated degradation of Wip1. Co-treatment of cells with MG-132 (Cat. No. 474790) reverses the reduction in Wip1 levels in cells. Enhances phosphorylation of Chk2 (Thr68), p53 (Ser15), H2AX (Ser139), and ATM (Ser1981) and upregulates the levels of p21/WAF1 in various tumor cells. Shown to block the growth of hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53, but does not affect BT474 cells carrying mutant p53 and amplified Wip1. Due to its short half life and reversible action, a sustained inhibition is warranted to block tumor growth. Reduces the growth of DOHH2 lymphoma tumor xenografts in mice (~150 mg/kg, p.o. bid or tid).

Please note that the molecular weight for this compound is batch-specific due to variable water content.

Biochem/physiol Actions

Cell permeable: yes
Primary Target
Reversible: yes
Target IC50: 6 nM for dephosphorylation of fluorescein diphosphate by Wip1 (2-240) and 13 nM for phospho-p38 MAP kinase (Thr180)


Packaged under inert gas


Toxicity: Standard Handling (A)


Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

Other Notes

Gilmartin, A.G., et al. 2014. Nature Chem. Biol.10, 181.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

11 - Combustible Solids



Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

Product numbers are combined with Pack Sizes/Quantity when displayed on the website (example: T1503-25G). Please make sure you enter ONLY the product number in the Product Number field (example: T1503).


Product Number
Pack Size/Quantity

Additional examples:





enter as 1.000309185)

Having trouble? Feel free to contact Technical Service for assistance.

Lot and Batch Numbers can be found on a product's label following the words 'Lot' or 'Batch'.

Aldrich Products

  • For a lot number such as TO09019TO, enter it as 09019TO (without the first two letters 'TO').

  • For a lot number with a filling-code such as 05427ES-021, enter it as 05427ES (without the filling-code '-021').

  • For a lot number with a filling-code such as STBB0728K9, enter it as STBB0728 without the filling-code 'K9'.

Not Finding What You Are Looking For?

In some cases, a COA may not be available online. If your search was unable to find the COA you can request one.

Request COA

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service